EUVIMEDEUVIMED entdecken
Crossref

A RANKL-derived Peptide Inhibits RSPO3-LGR4-Wnt Signaling and Lung Adenocarcinoma in Mice

Nan Ju, Hiroki Hayashi, Chinyang Chang, Hironori Nakagami, Ryuichi Morishita, Munehisa Shimamura

Anticancer Research · 2026

DOI: 10.21873/anticanres.18178 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Nan Ju und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gene & Stem Cell Regenerative Therapy, Graduate School of Medicine, The University of Osaka, Suita, Japan. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Thrombospondins, Lung Neoplasms, Adenocarcinoma of Lung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, G-Protein-CoupledThrombospondinsLung NeoplasmsAdenocarcinoma of LungWnt Signaling PathwayRANK LigandPeptidesAnimalsHumansR-SpondinsMiceXenograft Model Antitumor AssaysA549 CellsMice, NudeCell ProliferationMice, Inbred BALB CCell MovementMale

Stichwörter der Autor:innen

LGR4Lung adenocarcinomaR-spondinRANKL

Substanzen

Receptors, G-Protein-CoupledR-SpondinsThrombospondinsLGR4 protein, humanRSPO3 protein, humanRANK LigandPeptides

Autor:innen und Institutionen

  • Department of Gene & Stem Cell Regenerative Therapy, Graduate School of Medicine, The University of Osaka, Suita, Japan.
  • Department of Health Development and Medicine, Graduate School of Medicine, The University of Osaka, Suita, Japan.
  • Department of Clinical Gene Therapy, Graduate School of Medicine, The University of Osaka Suita, Japan.
  • Department of Gene & Stem Cell Regenerative Therapy, Graduate School of Medicine, The University of Osaka, Suita, Japan; shimamuu@cgt.med.osaka-u.ac.jp.
  • Department of Neurology, Graduate School of Medicine, The University of Osaka, Suita, Japan.

Zitieren

APA

Ju, N., Hayashi, H., Chang, C., Nakagami, H., Morishita, R., & Shimamura, M. (2026). A RANKL-derived Peptide Inhibits RSPO3-LGR4-Wnt Signaling and Lung Adenocarcinoma in Mice. Anticancer Research. https://doi.org/10.21873/anticanres.18178

Vancouver

Ju N, Hayashi H, Chang C, Nakagami H, Morishita R, Shimamura M. A RANKL-derived Peptide Inhibits RSPO3-LGR4-Wnt Signaling and Lung Adenocarcinoma in Mice. Anticancer Research. 2026. doi:10.21873/anticanres.18178

BibTeX
@article{Ju2026,
  author = {Ju, Nan and Hayashi, Hiroki and Chang, Chinyang and Nakagami, Hironori and Morishita, Ryuichi and Shimamura, Munehisa},
  title = {A RANKL-derived Peptide Inhibits RSPO3-LGR4-Wnt Signaling and Lung Adenocarcinoma in Mice},
  journal = {Anticancer Research},
  year = {2026},
  doi = {10.21873/anticanres.18178}
}
Kostenlos starten →